Nautilus Biotechnology stockholders elect three Class I directors and ratify PwC as auditor

Nautilus Biotechnology, Inc.

Sujal Patel, Vijay Pande, and Michael Altman elected as Class I directors with ~68.5M votes each.
Broker non-votes of 11,840,796 shares on director election.
Ratification of PricewaterhouseCoopers as independent auditor: 80.9M for, 31,871 against.
81,224,940 shares represented (65.3% of 124,456,653 outstanding shares).

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.